DAVPX
Price
$34.72
Change
-$0.55 (-1.56%)
Updated
Sep 6 closing price
GAFFX
Price
$71.60
Change
-$1.54 (-2.11%)
Updated
Sep 6 closing price
Ad is loading...

DAVPX vs GAFFX

Header iconDAVPX vs GAFFX Comparison
Open Charts DAVPX vs GAFFXBanner chart's image
Davenport Core Leaders Fund
Price$34.72
Change-$0.55 (-1.56%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F3
Price$71.60
Change-$1.54 (-2.11%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DAVPX vs GAFFX Comparison Chart
Loading...
VS
DAVPX vs. GAFFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAVPX is a Buy and GAFFX is a Buy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 270B vs. DAVPX (1.02B). GAFFX pays higher dividends than DAVPX: GAFFX (0.75) vs DAVPX (0.28). DAVPX was incepted earlier than GAFFX: DAVPX (27 years) vs GAFFX (8 years). GAFFX is a more actively managed with annual turnover of: 31.00 vs. DAVPX (19.00). DAVPX has a lower initial minimum investment than GAFFX: DAVPX (5000) vs GAFFX (1000000). GAFFX (18.82) and DAVPX (18.70) have marching annual gain over last year. GAFFX return over 5 years is better than : 47.91 vs. DAVPX (38.22).
DAVPXGAFFXDAVPX / GAFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years8 years-
Gain YTD11.75815.81974%
Front LoadN/AN/A-
Min. Initial Investment500010000001%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B270B0%
Annual Yield % from dividends0.280.7537%
Returns for 1 year18.7018.8299%
Returns for 3 years1.89-6.59-29%
Returns for 5 years38.2247.9180%
Returns for 10 years89.28N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DM4.380.11
+2.58%
Desktop Metal
ADEA11.90N/A
N/A
Adeia
CRVL311.13-0.03
-0.01%
CorVel Corp
CTSH76.78-0.54
-0.70%
Cognizant Technology Solutions Corp
AEON0.82-0.01
-1.46%
AEON Biopharma